Company History

During the late 1990s Percy Menzies was product director for DuPont pharmaceuticals when naltrexone was approved by the FDA for the treatment of alcohol dependence. With an extensive background in pharmacology and niche product knowledge, Mr. Menzies believed this medication had the ability, if used in conjunction with behavioral therapy and other behavioral modification tools, to change the lives of those who struggle with addiction. Shortly after DuPont withdrew from the product in late 1999, Mr. Menzies took early retirement and dedicated his life to addiction medicine. In early 2001 he founded the Assisted Recovery Centers of America to bring the treatment of addictive disorders into mainstream medicine.